245 related articles for article (PubMed ID: 25846830)
21. Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis.
Smolewska E; Brozik H; Smolewski P; Biernacka-Zielinska M; Darzynkiewicz Z; Stanczyk J
Ann Rheum Dis; 2003 Aug; 62(8):761-3. PubMed ID: 12860732
[TBL] [Abstract][Full Text] [Related]
22. The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity.
Gorczyca D; Postępski J; Czajkowska A; Paściak M; Prescha A; Olesińska E; Gruenpeter A; Lachór-Motyka I; Szponar B
Clin Rheumatol; 2017 Jun; 36(6):1269-1279. PubMed ID: 28247163
[TBL] [Abstract][Full Text] [Related]
23. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.
Schulert GS; Fall N; Harley JB; Shen N; Lovell DJ; Thornton S; Grom AA
Arthritis Rheumatol; 2016 Sep; 68(9):2300-13. PubMed ID: 27014994
[TBL] [Abstract][Full Text] [Related]
24. Investigation of Complement-activating Pattern Recognition Molecules and Associated Enzymes as Possible Inflammatory Markers in Oligoarticular and Systemic Juvenile Idiopathic Arthritis.
Petri C; Thiel S; Jensenius JC; Herlin T
J Rheumatol; 2015 Jul; 42(7):1252-8. PubMed ID: 26034144
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
26. [Early atherosclerosis changes in children with juvenile idiopathic arthritis].
Pietrewicz E; Urban M
Pol Merkur Lekarski; 2007 Mar; 22(129):211-4. PubMed ID: 17682678
[TBL] [Abstract][Full Text] [Related]
27. Changes in thiol/disulfide homeostasis in juvenile idiopathic arthritis.
Altinel Acoglu E; Erel O; Yazilitas F; Bulbul M; Oguz MM; Yucel H; Karacan CD; Senel S
Pediatr Int; 2018 Jun; 60(6):593-596. PubMed ID: 29569426
[TBL] [Abstract][Full Text] [Related]
28. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
Castro-Villegas C; Pérez-Sánchez C; Escudero A; Filipescu I; Verdu M; Ruiz-Limón P; Aguirre MA; Jiménez-Gomez Y; Font P; Rodriguez-Ariza A; Peinado JR; Collantes-Estévez E; González-Conejero R; Martinez C; Barbarroja N; López-Pedrera C
Arthritis Res Ther; 2015 Mar; 17(1):49. PubMed ID: 25860297
[TBL] [Abstract][Full Text] [Related]
29. The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively.
Orczyk K; Smolewska E
J Immunol Res; 2021; 2021():9473508. PubMed ID: 33575364
[TBL] [Abstract][Full Text] [Related]
30. [Association of vitamin D concentrations with juvenile idiopathic arthritis].
Wang Y; Lu MP; Teng LP; Guo L; Xu YP; Zou LX; Tong MQ
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):375-8. PubMed ID: 25919559
[TBL] [Abstract][Full Text] [Related]
31. [Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis].
Zhou YF; Li CF; Wang J; Han TX; Kuang WY; Deng JH; Zhang JM; Tan XH
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2487-9. PubMed ID: 24300271
[TBL] [Abstract][Full Text] [Related]
32. Serum Leucine-Rich
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
J Immunol Res; 2019; 2019():3140204. PubMed ID: 30863782
[TBL] [Abstract][Full Text] [Related]
33. Changes in vascular function and structure in juvenile idiopathic arthritis.
Vlahos AP; Theocharis P; Bechlioulis A; Naka KK; Vakalis K; Papamichael ND; Alfantaki S; Gartzonika K; Mavridis A; Michalis LK; Siamopoulou A
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1736-44. PubMed ID: 21905249
[TBL] [Abstract][Full Text] [Related]
34. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
[TBL] [Abstract][Full Text] [Related]
35. The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis.
Takahashi A; Mori M; Naruto T; Nakajima S; Miyamae T; Imagawa T; Yokota S
Mod Rheumatol; 2009; 19(3):302-8. PubMed ID: 19255829
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome.
Mizuta M; Shimizu M; Inoue N; Nakagishi Y; Yachie A
Cytokine; 2019 Jul; 119():182-187. PubMed ID: 30952065
[TBL] [Abstract][Full Text] [Related]
37. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-33 as a marker of disease activity in rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Ishikawa S; Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Mod Rheumatol; 2017 Jul; 27(4):609-613. PubMed ID: 27785924
[TBL] [Abstract][Full Text] [Related]
39. Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis.
Cantarini L; Giani T; Fioravanti A; Iacoponi F; Simonini G; Pagnini I; Spreafico A; Chellini F; Galeazzi M; Cimaz R
Yonsei Med J; 2012 Sep; 53(5):1045-8. PubMed ID: 22869491
[TBL] [Abstract][Full Text] [Related]
40. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
